Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A **peritoneal dialysis solution** containing magnesium chloride, dextrose monohydrate, sodium chloride, and sodium lactate, used as part of electrolyte and osmotic dialysis fluid formulations for the management of renal failure in patients undergoing peritoneal dialysis. This combination functions through **non-receptor-mediated physicochemical mechanisms**: dextrose provides the osmotic gradient that promotes ultrafiltration of excess water across the peritoneal membrane, while sodium, magnesium, and lactate help maintain electrolyte and buffer balance during dialysis exchange. In marketed products such as DELFLEX, this ingredient set is part of a broader multi-electrolyte formulation that also includes calcium chloride; therefore, the exact queried combination represents a **partial ingredient listing** rather than the complete branded product formulation. It is associated with treatment of chronic kidney failure and, more broadly, peritoneal dialysis use in acute or chronic renal failure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium chloride + dextrose monohydrate + sodium chloride + sodium lactate.